Abstract

Background: Nutritional status is intimately linked with pulmonary function and survival in cystic fibrosis (CF). The impact of elexacaftor-tezacaftor-ivacaftor (ETI) in weight gain remains incompletely described.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis
Lena Wucherpfennig ... Mark O Wielpütz
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | VOL. 21
Lena Wucherpfennig, et. al.Lena Wucherpfennig ... Mark O Wielpütz
08 Apr 2022
Improvement in body composition following a supervised exercise-training program of adult patients with cystic fibrosis
A Prévotat ... B Wallaert
Revue De Pneumologie Clinique | VOL. 75
A Prévotat, et. al.A Prévotat ... B Wallaert
16 Apr 2019
Association of Changes in Fitness and Body Composition with Cancer Mortality in Men
Peizhen Zhang ... Gregory A Hand
Medicine and science in sports | VOL. 46
Peizhen Zhang, et. al.Peizhen Zhang ... Gregory A Hand
01 Jul 2014
Resting respiratory variables and exercise capacity in adult patients with cystic fibrosis
G Perpati ... Ch Roussos
British Journal of Diseases of the Chest | VOL. 104
G Perpati, et. al.G Perpati ... Ch Roussos
01 Jul 2010
View more papers

More From: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Paper Title
Journal
Date
Author
Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies
Aleksandra Kowalik ... Lena Hjelte
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | VOL. -
Aleksandra Kowalik, et. al.Aleksandra Kowalik ... Lena Hjelte
13 Jun 2024
WS06.02 First-in-human clinical trial with SPL84, an ASO for treatment of cystic fibrosis patients carrying the 3849 +10 Kb C -> T mutation
E Kerem ... G Hart
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | VOL. 23
E Kerem, et. al.E Kerem ... G Hart
01 Jun 2024
P461 Agreement between peak power equations during cardiopulmonary exercise testing in cystic fibrosis
T Kent ... O Tomlinson
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | VOL. 23
T Kent, et. al.T Kent ... O Tomlinson
01 Jun 2024
P085 One-year of highly effective modulator therapy in children and young adults with cystic fibrosis: a single-centre experience
L Ronco ... I Esposito
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | VOL. 23
L Ronco, et. al.L Ronco ... I Esposito
01 Jun 2024
View more papers